Cargando…
Association between serum soluble Toll-like receptor 2 and 4 and the risk of breast cancer
Soluble Toll-like receptor (sTLR) 2 and 4 are endogenous negative regulators of TLR2 and TLR4 signaling. Therefore, the present study aimed to determine the serum levels of sTLR2 and 4, and to investigate the association between their levels and the clinicopathological parameters of patients with br...
Autores principales: | El-Kharashy, Ghada, Gowily, Ahmed, Okda, Tarek, Houssen, Maha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783720/ https://www.ncbi.nlm.nih.gov/pubmed/33414918 http://dx.doi.org/10.3892/mco.2020.2200 |
Ejemplares similares
-
Serum soluble Toll-like receptor 4 and the risk of hepatocellular carcinoma in hepatitis C virus patients
por: Elkammah, Maha, et al.
Publicado: (2021) -
Serum soluble toll-like receptor 2 and 4 as diagnostic and prognostic biomarkers for non-Hodgkin lymphoma
por: Fakhry, Nouran, et al.
Publicado: (2020) -
Associations Between Serum Soluble Toll-like Receptors 4 and 9 and Breast Cancer in Egyptian Patients
por: Moaz, Inas, et al.
Publicado: (2023) -
Links between Toll-like receptor 4 and breast cancer
por: Ahmed, Abubakr, et al.
Publicado: (2013) -
Soluble Toll-like receptor 4 is a potential serum biomarker in non-small cell lung cancer
por: Wei, Feng, et al.
Publicado: (2016)